Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women

By Adami Silvano  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3259-3274

Informa Healthcare

Access to resources Recommend Favorite

The use of teriparatide and PTH(1–84) for the treatment of osteoporosis

By Wagman Rachel   Miller Paul  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-290

Humana Press, Inc

Access to resources Recommend Favorite

Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration

By Scharla S.   Oertel H.   Helsberg K.   Kessler F.   Langer F.   Nickelsen T.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2393-2402

Informa Healthcare

Access to resources Recommend Favorite

Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis

By Migliore A.   Broccoli S.   Massafra U.   Bizzi E.   Frediani B.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 467-473

Informa Healthcare

Access to resources Recommend Favorite

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite